Mammalian Expression Systems
The main advantage of mammalian cell expression is that the mammalian cells can properly and efficiently recognize the signals for synthesis, processing and secretion of eukaryotic proteins. Therefore expression systems utilizing mammalian cells for recombinant protein manufacture are able to introduce proper protein folding, post-translational modifications, and protein assembly, which are important for complete biological activity. Extending to the pharmaceutical field, almost all biopharmaceutical companies in the world rely on the use of mammalian-cell-based stable cell lines for the manufacture of biologics.
Creative BioMart has decades of experience and expertise in both transient and stable expression based on HEK293 or CHO cell lines. Our advanced mammalian cell platform comprises improved promoters, signal sequences, vectors and transfection procedures. Additional yield enhancement through better expression and purification strategies further improves cost efficiency for the recombinant proteins.
Creative BioMart has extensive experience in vector optimization and has developed a set of proprietary vectors for preferred production cell types including HEK293 cells and CHO cells.
|HEK293 cells||CHO cells|
Creative BioMart provides comprehensive mammalian cells expression service, including bioinformatics analysis, protein domain selection, tag selection, construct design, sequence verification, cell transfection, cell amplification, pilot expression, purification, yield optimization, scale up processing, and advanced protein analysis.
|1||Gene synthesis plus codon optimization||1-2 weeks||
|2||Clone target gene into expression vector||1 week|
|3||Transfect competent cells with transfer vector||1week|
|4||Protein expression and purification||2-4 weeks|
|5||Optional services [secondary purification, tag removal, endotoxin removal, protein labeling, activity assay, protein analysis, etc.]||1-2 weeks|
|6||Quality Control||<1 weeks|
Hacker D L, Balasubramanian S. Recombinant protein production from stable mammalian cell lines and pools. Current Opinion in Structural Biology. Volume 38, June 2016, Pages129-136